University of Kentucky College of Medicine

Lexington, Kentucky 40536-7001

3 studies enrolling now · 8 studies all time

What they study most

Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC), Adolescent Congenital Heart Disease, Candidemia, Candidiasis, Invasive, Head and Neck Cancer, Multiple Myeloma, Patient-Reported Outcome Measures (PROMs), Phenylketonuria (PKU), Pragmatic Trial, Resilience, Psychological, Resiliency-building Intervention, Smoking Cessation

Studies at this site

• A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. — Recruiting now
• A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study — Recruiting now
• A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection — Recruiting now
• Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria — Running, not enrolling
• Phase 2 Study of Carfilzomib in Relapsed Multiple Myeloma — Completed
• Tobacco Treatment Medical Education in 10 Medical Schools — Completed
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer — Status unconfirmed
• A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT — Stopped early